# The Impact of Sugammadex on Ileus After Abdominal Wall Reconstruction

> **NCT05985343** · PHASE4 · COMPLETED · sponsor: **Clayton Petro** · enrollment: 184 (actual)

## Conditions studied

- Hernia, Ventral
- Ileus

## Interventions

- **DRUG:** Neostigmine / Glycopyrrolate
- **DRUG:** Sugammadex

## Key facts

- **NCT ID:** NCT05985343
- **Lead sponsor:** Clayton Petro
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-01-15
- **Primary completion:** 2025-05-30
- **Final completion:** 2025-06-02
- **Target enrollment:** 184 (ACTUAL)
- **Last updated:** 2025-11-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05985343

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05985343, "The Impact of Sugammadex on Ileus After Abdominal Wall Reconstruction". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05985343. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*